直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

At the PTAB Blog

Divided Federal Circuit Panel Upholds Non-Appealable Nature of PTAB Institution Decisions (Part II)

February 10, 2015

Authored and Edited by Anthony A. Hartmann

In part I, we provided an overview of the Federal Circuit’s opinion in In Re Cuozzo Speed Technologies, LLC. In part II, we focus on the opinion’s analysis of the non-appealability of PTAB institution decisions.

Cuozzo argued that the PTO improperly instituted IPR on two claims when it relied on prior art not identified in the Petition as applicable to those claims (but applicable to a dependent claim). However, the majority sided with the PTO, finding that the institution decision should not be reviewed on appeal.

In St. Jude Medical, the Federal Circuit had previously held that 35 U.S.C. § 314(d) bars interlocutory review of the PTO’s denial of a petition for IPR, but had not decided whether it barred review of an institution decision after a final written decision. Here, the majority concluded that § 314(d) does prohibit such a review. The majority relied heavily on the express language of § 314(d) that an institution decision is both “nonappealable” and “final,” stating that “[a] declaration that the decision to institute is ‘final’ cannot reasonably be interpreted as postponing review until after issuance of a final decision on patentability.” The majority further noted that since other sections of the statute already limit appeals to appeals of final decisions, § 314(d) could not be limited to interlocutory appeals, and must be read to bar review of all institution decisions.

In response to Cuozzo’s argument that Congress would not have intended to allow the PTO to institute IPR in direct contravention of the statute, the majority noted that “mandamus may be available” to challenge the PTO’s institution decision after a final decision in situations where the PTO has clearly and indisputably exceeded its authority. The majority noted that, if § 314 does not absolutely bar mandamus, it is very difficult to satisfy the three conditions for mandamus, noting that the present situation “is far from satisfying the clear-and-indisputable requirement for mandamus.”

Judge Newman’s vigorous dissent addressed the non-appealability issue. She opined that the lack of reviewability impedes full judicial review of the PTAB’s final decision, contrary to the purpose of the AIA to achieve correct adjudication of patent validity through IPRs. She asked whether the majority’s holding was “a curious departure from the fundamental rule of administrative action, that agency decisions must be reviewable on appeal?”

Tags

Aqua Products v. Matal, United States Court of Appeals for the Federal Circuit (CAFC), Cuozzo Speed Technologies LLC v. Lee, Final Written Decision

Related Practices

Patent Office Invalidation Proceedings

PTAB Invalidation Proceedings: IPR and PGR

Contacts

Anthony A. Hartmann
Of Counsel
Washington, DC
+1 202 408 4275
Email

Copyright © 2015 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 

DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. Additional disclaimer information. 

Related Insights

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Webinar

Changes at the PTAB from Settled Expectations to Real Parties in Interest to Director Involvement

May 18, 2026

Webinar

Federal Circuit IP Blog

Federal Circuit Affirms § 102(b) Invalidity; Source Code Commands Are Not Hearsay

May 14, 2026

Federal Circuit IP Blog

When “and” and “e.g.” Matter: Federal Circuit Revives VLSI vs. Intel Case

May 14, 2026

IP Updates

Tenth Circuit Sides with Netflix in Tiger King Copyright Challenge 

May 5, 2026

Conference

International Trade Commission Litigation & Enforcement

May 4-5, 2026

Washington, DC

Articles

Unpacking Squires’ Recent Discretionary Denial Guidance Focusing on American Manufacturing

April 24, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP